Delivery Order SPE2DB20D1109-SPE2DB23FP55M
- Not listed
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,001.19 firm fixed price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is a $32,335.86 firm fixed price delivery order with a completion date of January 21, 2025. AmerisourceBergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the military and veterans' healthcare systems. This contract is...
- The federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The fixed-price, firm-fixed delivery order, valued at $1,861.44, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,347.94 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,303.78 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors from Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA). The $3,133.65 firm fixed-price delivery order was awarded on March 17, 2023 with a completion date of March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,144.28, is a firm fixed-price delivery order with an ultimate completion date of October 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is registered in the System for Award Management (SAM.gov)...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,180.52 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 17, 2023, with a completion date of January 18, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key supplier of...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injector devices to the Defense Logistics Agency (DLA). The $3,655.71 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $2,119.53 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, on December 7, 2022, with a completion date of December 8, 2023. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., and is a major pharmaceutical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP55MDelivery Order
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors for the Defense Logistics Agency (DLA). The $3,617.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of July 19, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to the U.S. federal government, with a significant focus on supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering essential pharmaceutical and medical commodities to military treatment facilities and VA programs globally. This specific delivery order is part of that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/18/23 |